
In April 2017, the drug was approved to treat the slow loss of the ability to walk for symptomatic patients aged 3 and older who had Batten disease.

In April 2017, the drug was approved to treat the slow loss of the ability to walk for symptomatic patients aged 3 and older who had Batten disease.

The authors emphasize that clinical research should focus on real-world difficulties, and pediatric asthma control should be seen as a health care priority.

Unique gut flora were found in children with autism spectrum disorder (ASD).

The authors emphasize that these findings suggest a need for targeted resources that help reduce boarding and promote equitable access to care.

Higher vaccination rates were associated with less prevalent asthmatic symptoms, but additional research is needed to confirm these findings.

In 2 different dose groups, the majority of patients with eosinophilic esophagitis aged 1 to 11 achieved histologic remission at week 16 compared with patients treated with placebo.

However, more research is needed to effectively integrate this biomarker into individualized asthma management strategies for pediatric patients.

The findings show that the largest gaps are among pediatric patients with persistent asthma.


Autism spectrum disorder was also evaluated in the analysis, but further research is required to determine a possible association with relative age effect.

Secondhand exposure to e-cigarette smoke may increase risk of pediatric atopic dermatitis in children.

The study results also found that exposure to tree canopy area may protect children from asthma development; however, efficacy decreased as weed pollen exposure increased.

Trametinib may become an alternative treatment to hematopoietic stem cell transplantation in patients with relapsed or refractory juvenile myelomonocytic leukemia (JMML).

The indication is for the improvement of glycemic control in pediatric patients aged 10 and older with type 2 diabetes and comes after positive results from the phase 3 T2NOW clinical trial.

Parents and caregivers sometimes have concerns about their children receiving these injections, but researchers and experts assure that the FDA-approved biologic is safe and effective in young populations.

Polyarticular juvenile idiopathic arthritis is a form of arthritis that affects multiple joints at one time.

The authors noted that these networks have a significant role in intellectual ability, physical coordination, working memory, emotional processing, and overall mental health.

Approximately 40% of caregivers make dosing errors when administering liquid medication to children.

Evidence indicates that up to 25% of all prescriptions for children could be dosed inappropriately, making it the most common type of medication administration error.

Patients with sickle cell disease with more than a 6-month delay transitioning from pediatric to adult care were about twice as likely to be hospitalized.

The treatment is the first liquid non-stimulant for attention deficit hyperactivity disorder to be approved in the United States.

Researchers aimed to explore impacts of omega-3 fatty acids on children’s behavior, mood, and sleep.

The findings demonstrated that daytime heat waves were associated with approximately 19% higher odds of asthma-related hospitalizations in children.

The incident highlights the benefits of out-of-court settlements in civil cases

The study data demonstrate that higher adiposity in childhood results in less dense breast tissue forming, reducing the risk of breast cancer.